Drug Profile
Research programme: biodefense antiviral vaccines - Bavarian Nordic
Alternative Names: Coxsackievirus vaccine - Bavarian Nordic; Foot and mouth disease vaccine - Bavarian Nordic; Marburg virus vaccine - Bavarian Nordic; MVA-BN FMDV; Smallpox-Marburg virus vaccine - Bavarian NordicLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Bavarian Nordic
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Coxsackievirus infections; Marburg virus disease; Smallpox
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Coxsackievirus-infections in Denmark (Parenteral)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Marburg virus disease in Denmark (Parenteral)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Smallpox in Denmark (Parenteral)